Zobrazeno 1 - 10 of 16 pro vyhledávání: '"Austin Arrigo"'
1
Transgenic mouse models of breast cancer
Autor: Hui-Wen Lo, Grace L. Wong, Angelina T. Regua, Austin Arrigo, Daniel Doheny
Publikováno v: Cancer Lett
Transgenic breast cancer mouse models are critical tools for preclinical studies of human breast cancer. Genetic editing of the murine mammary gland allows for modeling of abnormal genetic events frequently found in human breast cancers. Genetically
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abb59c25746d200d82030ae8dbf2f838
https://doi.org/10.1016/j.canlet.2021.05.027
Zobrazit plný text záznamu
2
Tumor Suppressor Candidate 2 (TUSC2): Discovery, Functions, and Cancer Therapy
Autor: Austin Arrigo, Angelina T. Regua, Mariana K. Najjar, Hui-Wen Lo
Publikováno v: Cancers. 15:2455
Tumor Suppressor Candidate 2 (TUSC2) was first discovered as a potential tumor suppressor gene residing in the frequently deleted 3p21.3 chromosomal region. Since its discovery, TUSC2 has been found to play vital roles in normal immune function, and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e67eb379252d3f75df5d21830982245b
https://doi.org/10.3390/cancers15092455
Zobrazit plný text záznamu
3
Abstract 2603: Investigating TUSC2 for its tumor suppressive functions in glioblastoma and its role in gliomagenesis
Autor: Austin Arrigo, Mariana Najjar, Angelina Regua, Hui-Wen Lo
Publikováno v: Cancer Research. 83:2603-2603
The role of Tumor Suppressor Candidate 2 (TUSC2) in glioblastoma (GBM) is still poorly understood. Our recent study (Cancer Letters, 2022) reported, for the first time, that TUSC2 functions as a novel tumor suppressor for GBM. In this report, we foun
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2d9903cd0387d71465c3578c50b9c2d2
https://doi.org/10.1158/1538-7445.am2023-2603
Zobrazit plný text záznamu
5
TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers
Autor: Angelina T. Regua, Grace L. Wong, Austin Arrigo, Sara Abu Jalboush, Jiayuh Lin, Alexandra Thomas, Jimmy Ruiz, Roy E. Strowd, Sara G. Manore, Daniel Doheny, Yang Yu, Noah R. Aguayo, Dongqin Zhu, Calvin J. Wagner, Guangxu Jin, Peiqing Sun, Michael D. Chan, Hui-Wen Lo
Publikováno v: Cancers
Cancers, Vol 13, Iss 2340, p 2340 (2021)
Volume 13
Issue 10
JAK2–STAT3 and TrkA signaling pathways have been separately implicated in aggressive breast cancers
however, whether they are co-activated or undergo functional interaction has not been thoroughly investigated. Herein we report, for the first
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ca55504ccc6cefa2f5d7909c922d017
https://pubmed.ncbi.nlm.nih.gov/34066153
Zobrazit plný text záznamu
6
Abstract 92: tGLI1 and IL-6/IL-6R/GP130/STAT3 pathways cooperate to promote breast cancer stem cells and are co-activated in HER2-enriched and triple-negative breast cancers
Autor: Sara G. Manore, Daniel L. Doheny, Dongqin Zhu, Grace L. Wong, Angelina T. Regua, Austin Arrigo, Calvin J. Wagner, Mariana Najjar, Hui-Wen Lo
Publikováno v: Cancer Research. 82:92-92
Breast cancer is the most frequently diagnosed cancer and second leading cause of cancer-related deaths in women; 30% of primary breast cancer cases will develop distant metastases. The majority (90%) of breast cancer-related deaths are due to distan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::123cb1e672e26c326404868fb17f60ec
https://doi.org/10.1158/1538-7445.am2022-92
Zobrazit plný text záznamu
7
Abstract 1039: TrkA and JAK2-STAT3 pathway crosstalk promotes breast cancer stem cells in HER2-enriched and triple-negative breast cancers
Autor: Angelina T. Regua, Dongqin Zhu, Daniel L. Doheny, Grace L. Wong, Sara G. Manore, Calvin J. Wagner, Austin Arrigo, Mariana Najjar, Hui-Wen Lo
Publikováno v: Cancer Research. 82:1039-1039
Breast cancer is the most commonly diagnosed cancer in American women and accounts for ~15% of cancer-related deaths. Despite the current standard of care, metastatic HER2-enriched breast cancer and triple-negative breast cancer remain difficult to t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7150630dd9b4df58fc7c38d947f54476
https://doi.org/10.1158/1538-7445.am2022-1039
Zobrazit plný text záznamu
8
Abstract 2354: Astrocytes activated by tGLI1-expressing breast cancer brain metastases upregulate CNTF to activate astrocytes and promote breast cancer stem cells
Autor: Grace L. Wong, Sherona R. Sirkisoon, Noah R. Aguayo, Daniel L. Doheny, Dongqin Zhu, Angelina T. Regua, Austin Arrigo, Sara G. Manore, Calvin J. Wagner, Alexandra Thomas, Ravi Singh, Fei Xing, Guangxu Jin, Kounosuke Watabe, Hui-Wen Lo
Publikováno v: Cancer Research. 82:2354-2354
Breast cancer is the most frequently diagnosed cancer, and second most common source of brain metastasis in women. Despite recent advances in detection and therapeutics, patients with breast cancer brain metastases (BCBM) survive only 6-18 months aft
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5d5251030f33612c40c066f725443354
https://doi.org/10.1158/1538-7445.am2022-2354
Zobrazit plný text záznamu
9
Trk receptor tyrosine kinases in metastasis and cancer therapy
Autor: Angelina T, Regua, Daniel, Doheny, Austin, Arrigo, Hui-Wen, Lo
Publikováno v: Discovery medicine. 28(154)
Tropomyosin receptor kinases (TRKs) were first identified in 1986 when NTRK1 was discovered as part of an oncogenic fusion gene in colorectal cancer and the discovery of NTRK2 and NTRK3 followed shortly after. In the decades since their discovery, TR
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a41e35ecf7d485d964097bb4a4aa11f2
https://pubmed.ncbi.nlm.nih.gov/31928627
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje